Cadila Pharmaceuticals launches Vasograin EC with US FDA-approved formulation for migraine relief
Reformulated Vasograin EC manufactured in USFDA-approved facility; retains leading position in ergotamine segment
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Cadila Pharmaceuticals
Cadila Pharma launches Cadilose, a lactulose solution for constipation and hepatic encephalopathy
Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the…
Cadila Pharmaceuticals expands warehouse to strengthen logistics and market reach
Cadila Pharmaceuticals expands its warehouse facility to enhance operational efficiency, streamline logistics, and support growing…
Cadila Pharmaceuticals launches iron supplement ‘Militol’
Militol’s supplements contain ferric maltol, a low-dose form of ferric iron complexed with maltol and folic acid
Charting India Pharma Inc’s growth path
Pharma leaders and experts highlight opportunities in the life sciences industry, address critical issues and explore development…
Cadila Pharma launches under eye cream
The Cahaya Naturals Under Eye Cream is formulated with L-Glutathione, Vitamin C and other natural extracts that are rich in…
Cadila Pharma’s rabies vaccine ‘ThRabis’ receives award at Golden Globe Tigers Awards
ThRabis is a three-dose recombinant nanoparticle-based rabies G protein vaccine
Cadila Pharma signs IIF with Odisha govt for pharma formulation manufacturing unit
The IIF was signed at Make in Odisha Conclave 2022 in Bhubaneswar
Cadila Pharmaceuticals expands oncology portfolio, launches Tarzed
Tarzed is available as 440 mg injection
New opportunities for India in global API market
V K Singh, Chief Operating Officer – Chemical SBU, Cadila Pharmaceuticals, traces the evolution of the API industry in India and…